Shanghai Pharma definition

Shanghai Pharma trademark as mentioned in this Section shall include the trademark, characters used in the trademark, logo, label, name, image and their combinations as detailed in Appendix G hereto —the Trademark Transfer Agreement. The “Two Certificates” and “Product Certificate or Product Approval” as mentioned in this Contract are detailed in Appendix I- Lists of “Two Certificates” and “Product Certificate or Product Approval”.
Sample 1Sample 2Sample 3
Shanghai Pharma trademark as mentioned in this Section shall include the trademark, characters used in the trademark, logo, label, name, image and their combinations as detailed in Appendix G hereto —the Trademark Transfer Agreement. The “Two Certificates” and “Product Certificate or Product Approval” as mentioned in this Contract are detailed in Appendix I- Lists of “Two Certificates” and “Product Certificate or Product Approval”. CHAPTER 11 SITE
Sample 1

Examples of Shanghai Pharma in a sentence

  • During the Reporting Period, the Company has not entered into any contract with any individual, company or corporation to manage or dispose all or any part of major business of Shanghai Pharma except for service contracts concluded with the management and those disclosed herein.

  • Of course, in today’s pharmaceutical industry, although institutions with ideas and abilities to host the Winter Olympics are rare, Shanghai Pharma is by no means unique.

  • The particulars of changes in the property, plant, equipment and invested properties of Shanghai Pharma during the Reporting Period are set out in Notes (15), (16) and (17) to Financial Statements prepared in accordance with the Chinese accounting standards for business enterprises and Notes 7, 8 and 9 to Financial Statements prepared in accordance with Hong Kong Reporting Standards.

  • The permit application will be processed under the Tier II procedures.

  • Based on these policies, Shanghai Pharma will conduct an in-depth analysis on the competition landscape so as to tap out product potential.

  • The particulars of changes in the property, plant, equipment and invested properties of Shanghai Pharma during the Reporting Period are set out in Notes (15), (16) and (17) to Appendix IV of the Financial Statements prepared in accordance with the Chinese accounting standards for business enterprises and Notes 7, 8 and 9 to Financial Statements prepared in accordance with Hong Kong Reporting Standards.

  • The Company has established Shanghai Pharma central institute and sub-institute, enterprise technology center at national level, and 10 provincial and municipal enterprise technology centers, overseas R&D centers, which together form the Company’s interactive and integrated R&D system.

  • The Company is expected to make strategic breakthroughs in terms of chemical and biological pharmaceuticals, TCM, medical devices, distribution services, E-retail and grand health to keep Shanghai Pharma under sustainable and healthy development to achieve mutual growth of shareholders and employees.

  • The net amount of cash flow generated by Shanghai Pharma from its operating activities is RMB1.349 billion during the Reporting Period, representing an increase of 1.01% on a year- on-year basis, providing a better cash inflow from the operating activities; the net amount of cash flow generated from the investing activities is RMB-1.909 billion; and the net amount of cash from generated from financing activities is RMB636 million.

  • Overview The year of 2016 was the beginning year of new round scrolling strategic planning of “Three Three Three Plus One” of Shanghai Pharma.

Related to Shanghai Pharma

  • CJI means criminal justice information collected by criminal justice agencies needed for the performance of their authorized functions, including, without limitation, all information defined as criminal justice information by the U.S. Department of Justice, Federal Bureau of Investigation, Criminal Justice Information Services Security Policy, as amended and all Criminal Justice Records as defined under §24-72-302, C.R.S.

  • China means the People’s Republic of China, excluding, for purposes of this Agreement, Hong Kong, the Macau Special Administrative Region of the PRC and Taiwan.

  • HKFE means the Hong Kong Futures Exchange Limited.

  • IMRO means the Irish Music Rights Organisation CLG.

  • CMBI means Chase Manhattan Bank International, an indirect wholly-owned subsidiary of Bank, located in Moscow, Russia, and any nominee companies appointed by it.

  • Siemens means Siemens AG (Germany) and its Affiliates.

  • IDT means intradepartmental transfer.

  • SAI means Statement of Additional Information.

  • CJA means the Courts of Justice Act, RSO 1990, c C-43, as amended;

  • Shire means Shire of Augusta Margaret River

  • WFOE has the meaning set forth in the Preamble of this Agreement.

  • LHSIA means the Local Health System Integration Act, 2006, and the regulations made under it, as it and they may be amended from time to time;

  • NPS means nominal pipe size.

  • SA means the booklet that describes the Health Care Coverage provided to Enrolled Members. The Subscriber Agreement(s) applicable to the initial Rating Period are listed in Section III.

  • Accenture means the Accenture entity that is a party to the Agreement and its Affiliates (collectively, “Accenture”).

  • We/Our/Us means the Underwriters named in the Schedule.

  • HKMA means the Hong Kong Monetary Authority.

  • Asia means Afghanistan, Australia, Bangladesh, Bhutan, Brunei, Cambodia, Mainland China, Hong Kong, India, Indonesia, Japan, Kazakhstan, Kyrgyzstan, Laos, Macau, Malaysia, Maldives, Mongolia, Myanmar, Nepal, New Zealand, North Korea, Pakistan, the Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Tajikistan, Thailand, Timor-Leste, Turkmenistan, Uzbekistan, and Vietnam.

  • NSC means the National Suppliers Council.

  • Radiologic technologist, limited means an individual, other than a licensed radiologic technologist,

  • Elan means Elan Corp and its Affiliates.

  • HKEx means Hong Kong Exchanges and Clearing Limited or its successors.

  • NTU means nephelometric turbidity unit;

  • EUWA means the European Union (Withdrawal) Act 2018;

  • Modern biotechnology means the application of:

  • CIMA means the Cayman Islands Monetary Authority whose contact details are available from www.cima.ky;